Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BROOKS LAB vs MYLAN (US) - Comparison Results

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 BROOKS LAB   MYLAN
EQUITY SHARE DATA
    BROOKS LAB
Mar-23
MYLAN
Dec-18
BROOKS LAB/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1423,978-   
Low Rs582,190-   
Sales per share (Unadj.) Rs25.61,830.6-  
Earnings per share (Unadj.) Rs-12.649.7-  
Cash flow per share (Unadj.) Rs-9.7392.5-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs29.91,980.4-  
Shares outstanding (eoy) m24.70514.50-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.91.7 231.6%   
Avg P/E ratio x-7.962.0 -12.8%  
P/CF ratio (eoy) x-10.37.9 -130.6%  
Price / Book Value ratio x3.31.6 214.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m2,4661,586,770 0.2%   
No. of employees `000NA35.0 0.0%   
Total wages/salary Rs m1600-   
Avg. sales/employee Rs Th026,910.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0730.7-  
INCOME DATA
Net Sales Rs m632941,863 0.1%  
Other income Rs m20-   
Total revenues Rs m634941,863 0.1%   
Gross profit Rs m-294243,719 -0.1%  
Depreciation Rs m70176,354 0.0%   
Interest Rs m2245,300 0.0%   
Profit before tax Rs m-38422,065 -1.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-73-3,510 2.1%   
Profit after tax Rs m-31125,575 -1.2%  
Gross profit margin %-46.525.9 -179.6%  
Effective tax rate %19.1-15.9 -120.0%   
Net profit margin %-49.12.7 -1,809.4%  
BALANCE SHEET DATA
Current assets Rs m276525,936 0.1%   
Current liabilities Rs m330383,465 0.1%   
Net working cap to sales %-8.615.1 -56.6%  
Current ratio x0.81.4 61.0%  
Inventory Days Days38784 462.9%  
Debtors Days Days73793 789.3%  
Net fixed assets Rs m820182,706 0.4%   
Share capital Rs m247501 49.3%   
"Free" reserves Rs m4930-   
Net worth Rs m7401,018,924 0.1%   
Long term debt Rs m01,099,746 0.0%   
Total assets Rs m1,0962,733,150 0.0%  
Interest coverage x-16.61.5 -1,115.0%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.60.3 167.4%   
Return on assets %-26.32.6 -1,015.8%  
Return on equity %-42.02.5 -1,672.9%  
Return on capital %-48.93.2 -1,539.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m-145195,719 -0.1%  
From Investments Rs m5-101,165 -0.0%  
From Financial Activity Rs m114-91,177 -0.1%  
Net Cashflow Rs m-261,621 -1.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 83.58 Rs / USD

Compare BROOKS LAB With: ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare BROOKS LAB With: KREBS BIOCHEMICALS  ERIS LIFESCIENCES  BACIL PHARMA  INNOVA CAPTAB LTD.  NATCO PHARMA  



Today's Market

Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising Sensex Today Rallies 599 Points | Private Banks Rally | 4 Reasons Why Indian Share Market is Rising(Closing)

After opening the day deep in red, Indian share markets reversed the trend as the session progressed and ended on firm footing.